Upadacitinib – March 2023

• Brand names:
  • Rinvoq®
• Pharmaceutical Company:
  • AbbVie Pty Ltd
• Condition/Indication: Non-radiographic axial spondyloarthritis
• Meeting Date: March 2023
• Public Summary Document (PSD) November 2022 March 2023 PBAC Meetings - (PDF 672KB)
• Public Summary Document (PSD) November 2022 March 2023 PBAC Meetings - (Word 99KB)

Related Public Summary Documents

• Upadacitinib – November 2022